|
EMCDDA expert meeting on the epidemiological indicator: Drug-related deaths (DRD) |
drd | methodology |
|
The ESPAD validity study in four countries in 2013 |
methodology | prevalence |
|
European Drug Report 2015: Trends and Developments |
alcohol | amphetamines | cannabis | chemistry | co-morbidity | cocaine | consumption rooms | crime | death | demand | drug-law offences | environmental indicators | epidemiology | evaluation | gender | hallucinogens | harm reduction | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | methodology | new psychoactive substances (NPS) | older people | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | Reitox | research | seizures | social exclusion | social reintegration | spice | statistics | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends | young people |
|
Drug use: an overview of general population surveys in Europe |
key indicators | methodology |
|
Summary of the 2011 ESPAD report |
alcohol | cannabis | methodology | trends | young people |
|
Summary of the 2007 ESPAD report |
alcohol | methodology | trends | young people |
|
Modelling drug use: methods to quantify and understand hidden processes |
methodology | trends |
|
Drug use in prison: assessment report |
methodology | prison |
|
Therapeutic communities for treating addictions in Europe: evidence, current practices and future challenges |
best practice | health effects | methodology | prevention | substance use disorders | substitution treatment | treatment |
|
Computer-assisted and online data collection in general population surveys |
methodology | schools |